Zika vaccine candidates progress through nonclinical development and enter clinical trials.
about
Protective efficacy of Zika vaccine in AG129 mouse modelDNA vaccination protects mice against Zika virus-induced damage to the testesCurrent status of Zika vaccine development: Zika vaccines advance into clinical evaluation.E90 subunit vaccine protects mice from Zika virus infection and microcephalyZika virus vaccinesComplementary Mechanisms Potentially Involved in the Pathology of Zika Virus
P2860
Zika vaccine candidates progress through nonclinical development and enter clinical trials.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Zika vaccine candidates progre ...... ent and enter clinical trials.
@en
Zika vaccine candidates progre ...... ent and enter clinical trials.
@nl
type
label
Zika vaccine candidates progre ...... ent and enter clinical trials.
@en
Zika vaccine candidates progre ...... ent and enter clinical trials.
@nl
altLabel
Zika vaccine candidates progre ...... ment and enter clinical trials
@en
prefLabel
Zika vaccine candidates progre ...... ent and enter clinical trials.
@en
Zika vaccine candidates progre ...... ent and enter clinical trials.
@nl
P2860
P1433
P1476
Zika vaccine candidates progre ...... ent and enter clinical trials.
@en
P2860
P2888
P356
10.1038/NPJVACCINES.2016.23
P577
2016-11-10T00:00:00Z
P6179
1051653861